LATAM Reishi Mushroom Market Size & Outlook, 2025-2033

LATAM Reishi Mushroom Market Insights

Based on Deep Market Insights findings, the LATAM Reishi Mushroom Market size reached USD 6.17 Million in 2024 and is expected to grow to USD 12.14 Million by 2033.
During 2026–2033, the market is forecasted to advance at a CAGR of 7.83%.
Powder represented the largest share of the Product Form market in terms of size in 2024.
Among the Product Form segments, Extracts is forecasted to achieve the highest growth and remain the most lucrative through the forecast period.

In 2024, LATAM contributed 6.22% to the overall global Reishi Mushroom Market size.
By 2033, United States is anticipated to dominate the global market based on market size.
Colombia is expected to witness the fastest growth within LATAM, attaining USD 0.94 Million by 2033.

Report Scope	Details
Base Year for Study	2024
Study Period	2021-2033
Historical Period	2021-2023
Forecast Period	2025-2033
Market Size In 2024	USD 6.17 Million
Market Size In 2033	USD 12.14 Million
Largest segment	Powder
Units	Revenue in USD Million
CAGR	7.83% (2025-2033)
Segmnetation Covered
LATAM	Brazil Mexico Argentina Colombia Chile
Product Form	Powder Capsules Extracts
Application	Dietary Supplements Functional Foods Traditional Medicine
Source	Wild Harvested Cultivated
Distribution Channel	Pharmacies Online Retail Specialty Stores
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

LATAM	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Brazil	XX.x	XX.x	XX.x	2.62	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Mexico	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Argentina	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Colombia	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Chile	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

Product Form	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Powder	XX.x	XX.x	XX.x	2.78	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Capsules	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Extracts	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

Application	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Dietary Supplements	XX.x	XX.x	XX.x	3.2	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Functional Foods	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Traditional Medicine	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

Source	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Wild Harvested	XX.x	XX.x	XX.x	3.99	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Cultivated	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

Distribution Channel	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033
Pharmacies	XX.x	XX.x	XX.x	3.06	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Online Retail	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Specialty Stores	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x